Dexmedetomidine and neuroprotection

Ellen L. Janke MD, Satwant Samra MD
{"title":"Dexmedetomidine and neuroprotection","authors":"Ellen L. Janke MD,&nbsp;Satwant Samra MD","doi":"10.1053/j.sane.2006.02.002","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Dexmedetomidine<span> is an α-2 adrenoreceptor agonist which has displayed neuroprotective properties in a variety of in vitro and in vivo laboratory studies; however, the mechanism of </span></span>neuroprotection<span> remains unclear. Modulation of pathways leading to excitatory cell death and apoptosis are likely to be involved, although there is evidence for and against these theories. Randomized </span></span>controlled clinical trials in humans are needed to ascertain the efficacy of dexmedetomidine as a neuroprotectant in humans before its clinical use as a neuroprotectant can be recommended.</p></div>","PeriodicalId":82686,"journal":{"name":"Seminars in anesthesia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sane.2006.02.002","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in anesthesia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277032606000183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Dexmedetomidine is an α-2 adrenoreceptor agonist which has displayed neuroprotective properties in a variety of in vitro and in vivo laboratory studies; however, the mechanism of neuroprotection remains unclear. Modulation of pathways leading to excitatory cell death and apoptosis are likely to be involved, although there is evidence for and against these theories. Randomized controlled clinical trials in humans are needed to ascertain the efficacy of dexmedetomidine as a neuroprotectant in humans before its clinical use as a neuroprotectant can be recommended.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
右美托咪定与神经保护作用
右美托咪定是一种α-2肾上腺受体激动剂,在各种体外和体内实验室研究中显示出神经保护特性;然而,神经保护的机制尚不清楚。导致兴奋性细胞死亡和凋亡的通路的调节可能参与其中,尽管有证据支持和反对这些理论。在推荐右美托咪定作为神经保护剂临床使用之前,需要在人类中进行随机对照临床试验,以确定右美托咪定作为神经保护剂在人类中的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Fat Embolism Syndrome Table of Contents Editorial board Introduction Ultrasound imaging in brachial plexus blockade
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1